Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
D
Dennis A. Eichenauer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
234
Papers
6.6K
Citations
42
h-index
90
i10-index
Dennis A. Eichenauer is an academic researcher from University of Cologne. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Viral-associated cancers and disorders. The author has an h-index of 42, co-authored 199 publications.
ORCID: 0000-0002-1927-3514Papers by this author
worksLong-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · JAMA · 45 citations
https://doi.org/10.1001/jama.2023.21407
Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group
2013 · British Journal of Cancer · 40 citations
https://doi.org/10.1038/bjc.2012.550
Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
2022 · Annals of Hematology · 30 citations
https://doi.org/10.1007/s00277-022-05054-9
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trials
2024 · Annals of Oncology · 12 citations
https://doi.org/10.1016/j.annonc.2024.12.009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat